Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 4
2001 1
2002 2
2003 2
2004 7
2005 2
2011 1
2012 2
2013 3
2014 2
2016 7
2017 5
2018 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG. Jankovic J, et al. Among authors: martin facklam m. JAMA Neurol. 2018 Oct 1;75(10):1206-1214. doi: 10.1001/jamaneurol.2018.1487. JAMA Neurol. 2018. PMID: 29913017 Free PMC article. Clinical Trial.
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside.
Bray-French K, Hartman K, Steiner G, Marban-Doran C, Bessa J, Campbell N, Martin-Facklam M, Stubenrauch KG, Solier C, Singer T, Ducret A. Bray-French K, et al. Among authors: martin facklam m. J Pharm Sci. 2021 Jul;110(7):2575-2584. doi: 10.1016/j.xphs.2021.03.027. Epub 2021 Apr 1. J Pharm Sci. 2021. PMID: 33812888 Free article. Review.
[Drug interactions with the cytochrome P-450 system].
Martin-Facklam M, Drewe J, Haefeli WE. Martin-Facklam M, et al. Dtsch Med Wochenschr. 2000 Jan 21;125(3):63-7. doi: 10.1055/s-2007-1023908. Dtsch Med Wochenschr. 2000. PMID: 10682001 Review. German. No abstract available.
[Clinically relevant adverse drug interactions].
Martin-Facklam M, Haefeli WE. Martin-Facklam M, et al. Ther Umsch. 2000 Sep;57(9):579-83. doi: 10.1024/0040-5930.57.9.579. Ther Umsch. 2000. PMID: 11036439 Review. German.
Inhibition of P-glycoprotein by newer antidepressants.
Weiss J, Dormann SM, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE. Weiss J, et al. Among authors: martin facklam m. J Pharmacol Exp Ther. 2003 Apr;305(1):197-204. doi: 10.1124/jpet.102.046532. J Pharmacol Exp Ther. 2003. PMID: 12649369
34 results